Thoracentesis (Pleurocentesis)

What Is a Thoracentesis (Pleurocentesis)?

A thoracentesis is a minimally invasive procedure. It removes fluid buildup from the pleural cavity using a hollow needle. Doctors also call the procedure a pleurocentesis.

When someone has mesothelioma, it can cause fluid to build up between the two layers of tissue that cover the lungs. This can lead to cough, chest pain, discomfort and breathing difficulties.

This condition is called a pleural effusion. It is healthy to have a small amount of fluid in the pleura. But excess fluid buildup puts pressure on one or both lungs. To help, doctors use a procedure called thoracentesis to remove the extra fluid and offer relief.

Thoracentesis has many names. Doctors call it pleural fluid aspiration, pleural tap, pleurocentesis and thoracocentesis.

A chest X-ray can reveal a pleural effusion but usually not the reason for it. Many different diseases can cause pleural effusions. Doctors examine the fluid collected through thoracentesis to try to identify the root cause.

Thoracentesis testing is not reliable enough to confirm a mesothelioma diagnosis. Diagnosis depends on analyzing a cancer tissue sample collected through a biopsy.

Palliative Thoracentesis Versus Other Treatments

Palliative therapies aim to relieve painful symptoms and improve a patient’s quality of life. Removing excess pleural fluid alleviates chest pain and shortness of breath. It reduces pressure on the chest and lungs and provides more space for the lungs to expand during respiration.

Thoracentesis has become less common as a mesothelioma treatment compared to other procedures:

Thoracentesis is tolerated well at all cancer stages. The procedure remains a tried-and-true technique for alleviating pleural effusion.

A 2021 study recorded the outcomes of 16 patients who underwent thoracentesis. After the procedure, breathlessness, chest pain and cough improved in some patients. They reported feeling and sleeping better, but fatigue and poor appetite remained. Participants were more active after aspiration, and many felt the procedure was worthwhile.

Surgical Consultation for Thoracentesis

A thoracentesis requires a surgical consultation even though it is considered a minimally invasive procedure. During the consultation, patients meet with the surgeon to learn more about the procedure and find out if they qualify. The surgeon will thoroughly review their medical records, imaging scans and biopsy results to determine if they are eligible.

Before surgery, it’s important to meet with the surgeon. This could be done in person or through video chat. You’ll have a chance to ask questions and get to know the surgeon better. They will also explain what you need to do before the procedure, how it will work and what recovery looks like afterward.  

What to Expect During a Thoracentesis Procedure

The patient may assume a seated position throughout the procedure or lie down if necessary. The doctor sterilizes the skin around the insertion point and provides local anesthesia to numb the area.

Next, the doctor inserts a long, hollow needle called a cannula between the ribs, guided by ultrasound or CT scan images. The patient may experience a feeling of pressure, but the anesthesia usually blocks any pain. Once the needle is inserted, the doctor drains the pleural effusion until some or all of the fluid is removed, depending on the goal of the thoracentesis. The entire process takes about 15 minutes.

The doctor usually sends the extracted fluid to a lab for analysis (pleural cytology). After removing the needle and dressing the wound, the doctor often orders a chest X-ray as well to confirm enough fluid was removed and to ensure there is no sign of a collapsed lung.

Risks and Complications

While complications are rare, they can occur. The most common serious complication of the procedure is a collapsed lung, also known as pneumothorax. This can happen if the doctor accidentally punctures the lung or disrupts an accumulation of air in the pleural cavity.

Complications are more common among certain groups of patients. Patients with a history of lung surgery face greater risks, as do patients with a chronic, irreversible lung disease such as asthma or emphysema. Patients with any condition that affects normal blood clotting may also face a higher risk of complications.

One 2010 study identified patients who would benefit most from thoracentesis while experiencing the lowest risk of complications. Out of 446 patients involved in the study, including a number of malignant mesothelioma patients, the incidence of pneumothorax was significantly lower in patients whose procedure was guided by an ultrasound.

Another factor that increased the risk of complications in participants was the presence of symptoms of their primary disease. Thoracentesis led to complications for only one asymptomatic patient (out of 328 total), yet 15 of 118 symptomatic patients developed complications.